The molecular, biochemical and human pharmacology of thromboxane A₂ in renal diseaseFITZGERALD, G. A; MURRAY, R; PRICE, P et al.Advances in experimental medicine and biology. 1989, Vol 259, pp 325-360, issn 0065-2598, 36 p.Article

Proceedings. II: Pharmacology of platelet inhibition/Symposium on platelet inhibition and vascular occlusion in man, London, England, August 1984Circulation (New York, N.Y.). 1985, Vol 72, Num 6, pp 1163-1225, issn 0009-7322Conference Proceedings

LE BIOESSAI DU THROMBOXANE A2VARGAFTIG BB.1978; REV. MED.; FRA; DA. 1978; VOL. 19; NO 42; PP. 2358-2360; ABS. ENG; BIBL. 8 REF.Article

The effects of platelet-derived contractile agents on human digital arteriesMOULDS, R. F. W; IWANOV, V; MEDCALF, R. L et al.Clinical science (1979). 1984, Vol 66, Num 4, pp 443-451, issn 0143-5221Article

A novel approach for the study of thromboxane A₂ and prostaglandin H₂ receptors using an ¹²⁵I-labeled ligandHALUSHKA, P. V; MACDERMOT, J; KNAPP, D. R et al.Biochemical pharmacology. 1985, Vol 34, Num 8, pp 1165-1170, issn 0006-2952Article

Effects of lipoxygenase inhibitors in arachidonate-induced sudden deathROTH, D. M; FEDUSKA, R; LEFER, A. M et al.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 3, pp 205-207, issn 0022-3573Article

The role of prostacyclin and thromboxane in sepsis and septic shockCARMONA, R. H; TSAO, T. C; TRUNKEY, D. D et al.Archives of surgery (Chicago, IL. 1960). 1984, Vol 119, Num 2, pp 189-192, issn 0004-0010Article

Local anesthetics inhibit thromboxane A₂ signaling in Xenopus oocytes and human K562 cellsHÖNEMANN, Christian W; HAHNENKAMP, Klaus; PODRANSKI, Tobias et al.Anesthesia and analgesia. 2004, Vol 99, Num 3, pp 930-937, issn 0003-2999, 8 p.Article

Inhibition of human platelet thromboxane generation by aspirin in the absence of measurable drug levels in peripheral bloodCERLETTI, C; LATINI, R; DEJANA, E et al.Biochemical pharmacology. 1985, Vol 34, Num 10, pp 1839-1841, issn 0006-2952Article

Anti-thrombotic effect of curcuminSRIVASTAVA, R; DIKSHIT, M; SRIMAL, R. C et al.Thrombosis research. 1985, Vol 40, Num 3, issn 0049-3848, O 413-417Article

Prostaglandin I₃ is formed in vivo in man after dietary eicosapentaenoic acidFISCHER, S; WEBER, P. C.Nature (London). 1984, Vol 307, Num 5947, pp 165-168, issn 0028-0836Article

Evidence of a thromboxane A₂-Ca²⁺ complex: a conformational approachBRASSEUR, R; RUYSSCHAERT, J.-M.Research communications in chemical pathology and pharmacology. 1984, Vol 46, Num 2, pp 175-185, issn 0034-5164Article

THROMBOXANE A₂ BIOSYNTHESIS IN HUMAN LUNG FIBROBLASTS WI-38HOPKINS NK; SUN FF; GORMAN RR et al.1978; BIOCHEM. BIOPHYS. RES. COMMUNIC.; USA; DA. 1978; VOL. 85; NO 2; PP. 827-836; BIBL. 28 REF.Article

LES THROMBOCYTOPATHIES PAR DEFICIT DE SYNTHESE DES ENDOPEROXYDES ET DU THROMBOXANE A₂DECHAVANNE M; FOLLEA G; TRZECIAK MC et al.1978; REV. MED.; FRA; DA. 1978; VOL. 19; NO 42; PP. 2353-2355; ABS. ENG; BIBL. 7 REF.Article

PLATELET AGGREGATION AND THROMBOXANE A₂ FORMATION IN CAT PLATELET RICH PLASMA.MARCINKIEWICZ E; GRODZINSKA L; GRYGLEWSKI RJ et al.1978; PHARMACOL. RES. COMMUNIC.; G.B.; DA. 1978; VOL. 10; NO 1; PP. 1-12; BIBL. 20 REF.Article

Heparin-induced platelet aggregation is inhibited by antagonists of the thromboxane pathwayMIKHAILIDIS, D. P; BARRADAS, M. A; DANDONA, P et al.Thrombosis research. 1986, Vol 42, Num 5, pp 719-720, issn 0049-3848Article

Differences in thromboxane A₂ synthesis by megakaryocytes and plateletsWOJENSKI, C. M; SCHICK, P. K.The Journal of laboratory and clinical medicine. 1991, Vol 118, Num 4, pp 370-376, issn 0022-2143Article

Cardiopulmonary function as related to thromboxane A₂ synthesis in experimental septic shockSCHÜTZER, K.-M; LINDHILM, E; HAGLUND, U et al.Circulatory shock. 1988, Vol 26, Num 1, pp 27-40, issn 0092-6213Article

A possible mechanism of airway hyperresponsiveness induced by prostaglandin F₂α and thromboxane A₂AIZAWA, H; HIROSE, T.Prostaglandins, leukotrienes and essential fatty acids. 1988, Vol 33, Num 3, pp 185-189, issn 0952-3278Article

The effect of thromboxane A₂ synthesis inhibitors on platelet aggregation in whole bloodLAD, N; LUNT, D. O; TUFFIN, D. P et al.Thrombosis research. 1987, Vol 46, Num 4, pp 555-566, issn 0049-3848Article

Sodium salicylate does not prevent the inhibitory effect of indomethacin on thromboxane formation in human blood ex vivoDAHL, M.-L; UOTILA, P.Prostaglandins leukotrienes and medicine. 1985, Vol 17, Num 1, pp 71-76, issn 0262-1746Article

Thrombopoietin increases platelet sensitivity to α-thrombin via activation of the ERK2-cPLA₂ pathwayVAN WILLIGEN, G; GORTER, G; AKKERMAN, J.-W. N et al.Thrombosis and haemostasis. 2000, Vol 83, Num 4, pp 610-616, issn 0340-6245Article

Thromboxan A₂ und Prophylaxe kardiovaskulärer Erkrankungen = Thromboxane A₂ and prophylaxis of cardiovascular diseaseSCHRÖR, K.Zeitschrift für Kardiologie. Supplementum. 1992, Vol 81, Num 4, pp 185-189, issn 0303-6308Conference Paper

Thromboxane A₂ receptor blockade improves contractile function following cardiopulmonary bypass in dogs and pigsKULATILAKE, N; GONZALEZ-LAVIN, L; GROVER, G. J et al.The Journal of surgical research. 1991, Vol 51, Num 4, pp 336-340, issn 0022-4804Article

Protective effects of the novel thromboxane A₂ receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-10-benzimidazolyl)-ethylidene]-6,11-dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy-9a,11a-epoxymethano-prostaglandin F_2α-induced sudden death in guinea-pigs and ratsSHIRAKURA, S; KARASAWA, A; KUBO, K et al.Arzneimittel-Forschung. 1991, Vol 41, Num 12, pp 1242-1245, issn 0004-4172Article